By the bioMérieux Connection Editors
Antimicrobial-resistant infections are undermining modern drugs and, if we do not take action, by 2050, more than 10 million people could die each year from antibiotic-resistant infections. In addition to this devastating loss of life, there could also be a considerable economic effect—antibiotic resistance could lead to as much as an eight trillion-dollar annual loss in global GDP.
Antimicrobial resistant bacteria are a “One Health” challenge, meaning that they can spread between people, animals, and the environment. In the first installment of bioMérieux’s 2021 Webinars to Advance Antimicrobial Stewardship Programs series, Christine C. Ginocchio, PhD, MT (ASCP), will discuss the “One Health” approach to fighting antimicrobial resistance, which is a collaborative, multi-sectoral, and transdisciplinary approach—working at the local, regional, national, and global levels—with the goal of achieving optimal health outcomes that recognize the connection between people, animals, plants, and their shared environment.
In addition to exploring the clinical and financial impact of antimicrobial resistance (AMR) through the lens of One Health, Dr. Ginocchio will also describe the Infectious Diseases Society of America’s (IDSA) recommendations relating to the diagnostic priorities for the National Action Plan on Combating Antibiotic-Resistant Bacteria 2020-2025, as specified by the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB).
PACCARB, which was established in September 2015 by Executive Order, is working at a national level to combat the threat of antimicrobial resistance. Membership consists of nationally recognized experts from both human and animal health domains within academia, the biomedical and pharmaceutical industry, public health, advocacy organizations, veterinary and agricultural fields. PACCARB’s three main duties are to advise, inform, and recommend.
Tune into the webinar on April 28, 2021 to learn more about how PACCARB and groups like the IDSA are working to further the use of diagnostic tests and the role of infectious disease professionals to help stem the threat of antimicrobial resistance. Click the button below for more information and to register!
Opinions expressed in this article are not necessarily those of bioMérieux, Inc.